Largest biotech companies by cash on hand

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

CG Oncology has the lowest figure of the 24 biotech companies ranked by cash on hand, at AED 119.3M, followed by Adaptive Biotechnologies (AED 258.9M) and ImmunityBio (AED 324.4M). Figures as of 18 Nov 2026, 23:52 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
Lowest
CG OncologyAED 119.3M
Median
AED 1.6B
Combined market value
AED 3.07T
Countries
5

Market values as of .

All countries
All sectors
Biotech
AED
Clear filters
Largest biotech companies by cash on hand
#CompanyCash on hand ↑Market capPriceToday1 yearPrice, 30 daysCountry
1CG OncologyCGON · Health CareAED 119.3MAED 26.2BAED 293.81 1.34% up 85% up United States
2Adaptive BiotechnologiesADPT · Health CareAED 258.9MAED 16.9BAED 104.52 0.11% down 88% up United States
3ImmunityBioIBRX · Health CareAED 324.4MAED 26.2BAED 24.61 7.03% up 193% up United States
4Halozyme TherapeuticsHALO · Health CareAED 491.5MAED 40.1BAED 351.84 0.18% down 37% up United States
5VaxcytePCVX · Health CareAED 638.9MAED 34BAED 214.92 1.48% down 22% up United States
6Twist BioscienceTWST · Health CareAED 672.3MAED 29.1BAED 427.31 3.88% up 340% up United States
7Kodiak SciencesKOD · Health CareAED 770.7MAED 23.5BAED 359.22 1.04% up 396% up United States
8Bio-TechneTECH · Health CareAED 972.2MAED 42BAED 267.18 0.17% up 26% up United States
9Scholar Rock HoldingSRRK · Health CareAED 1.2BAED 21.5BAED 176.28 6.48% up 14% up United States
10CRISPR TherapeuticsCRSP · Health CareAED 1.3BAED 14.3BAED 147.60 0.10% up 21% down Switzerland
11Kymera TherapeuticsKYMR · Health CareAED 1.3BAED 38BAED 444.86 0.32% down 87% up United States
12Revolution MedicinesRVMD · Health CareAED 1.4BAED 127BAED 586.95 1.76% down 131% up United States
13ExelixisEXEL · Health CareAED 1.8BAED 61.2BAED 250.80 0.31% down 63% up United States
14Krystal BiotechKRYS · Health CareAED 1.8BAED 34.3BAED 1,158.12 5.62% up 46% up United States
15RepligenRGEN · Health CareAED 2.1BAED 40.5BAED 634.15 6.47% up 5% up United States
16Neurocrine BiosciencesNBIX · Health CareAED 2.6BAED 60.5BAED 598.12 1.84% down 20% up United States
17QiagenQGEN · Health CareAED 3.1BAED 37.6BAED 182.01 0.38% down 12% up Netherlands
18ImmunovantIMVT · Health CareAED 3.3BAED 25.2BAED 121.82 0.12% down 43% up United States
19ModernaMRNA · Health CareAED 9.5BAED 292.4BAED 722.73 4.84% down 755% up United States
20BiogenBIIB · Health CareAED 11BAED 136.5BAED 923.33 0.25% up 49% up United States
21argenxARGX · Health CareAED 12.8BAED 217.4BAED 3,456.83 0.66% down 4% up Belgium
22Gilead SciencesGILD · Health CareAED 27.8BAED 769.7BAED 620.60 0.75% down 33% up United States
23BioNTechBNTX · Health CareAED 31.3BAED 75.8BAED 305.78 1.89% down 16% down Germany
24AmgenAMGN · Health CareAED 33.5BAED 881.8BAED 1,630.23 3.07% down 34% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 3.6726 AED).

Questions and answers

Which biotech companies have the lowest cash on hand?

CG Oncology (AED 119.3M), Adaptive Biotechnologies (AED 258.9M) and ImmunityBio (AED 324.4M) have the lowest cash on hand of the 24 biotech companies ranked here as of 18 Nov 2026, 23:52 UTC.

How many biotech companies are in this ranking?

24 are ranked by cash on hand.

What are these biotech companies worth together?

The 24 biotech companies ranked by cash on hand have a combined market value of AED 3.07T as of 18 Nov 2026, 23:52 UTC.

What does ranking by cash on hand measure?

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

Cite this page

Funkfolio, “Largest biotech companies by cash on hand”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=cash-on-hand

Underlying data: Yahoo Finance; SEC EDGAR.